Research Note english - Expedeon AG - 07.10.19
Expedeon's innovative technologies, products and services are used in research laboratories worldwide, enabling scientists to break down the boundaries of research and product development and make significant contributions to bringing new diagnostic tools to market. With applications covering the entire genomics, proteomics and immunology workflow, Expedeon's technologies accelerate and simplify research and enable both biopharmaceutical and diagnostic companies and organisations to introduce new and costeffective processes. This is how Expedeon is supporting its commercial customers in their development and marketing goals. Academic customers can use Expedeon products to produce reliable and reproducible results more quickly. Expedeon's products are available through direct distribution and a number of distribution partners in Europe, the USA and Asia. Expedeon AG has branches in Germany, Spain, the UK, US and Singapore.
SYGNIS is a holding company. Through its subsidiaries, Co. is engaged in the development and marketing of molecular-diagnostic technologies. Specifically, Co. is engaged in the technologies and tools for DNA amplification and sequencing: QualiPhi, a version of the wildtype Phi29 polymerase with higher affinity to DNA; QualiPhi mutants, a novel mutants developed for the need of Next Generation Sequencing; PrimPol, an enzyme acquired from the thermophilic bacteria Thermus thermophilus; Double Switch, a cell based technology for the measurement of protein-protein interactions.; and DNA Repair Kit, a combination of enzymes to partially “repair” DNA.
Die GBC AG mit Sitz in Augsburg ist eines der führenden bankenunabhängigen Investmenthäuser in Deutschland und erfahrener Emissionsexperte für den deutschen Mittelstand.
Die GBC AG kennt als eigentümergeführtes Unternehmen die Bedürfnisse des deutschen Mittelstandes im Finanzierungsbereich und ist ein unabhängiger und verlässlicher Partner bei allen Fragestellungen rund um den Kapitalmarkt.
In der GBC Gruppe bietet die GBC AG Unternehmensanalysen & Research, Kapitalmarkt- & Finanzierungsberatungen sowie Kapitalmarktkonferenzen.
Die GBC Kapital GmbH ergänzt die Leistungen in der Gruppe um das Corporate Finance in den Bereichen Platzierung & Vermittlung von Anleihen und Aktien
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.